Knee Osteoarthritis Clinical Trial Update: FDA Submission and Results
We have officially submitted data to the FDA for our knee osteoarthritis clinical trial and the preliminary results look promising!
Using Stem Cell Therapy to Combat Osteoarthritis
Though there is still much to learn about the therapeutic effects of stem cell therapy, stem cell research has come a long way in the past few decades. Through a multitude of studies for a variety of conditions, researchers have made many important discoveries...
Stem Cell Sources: Adipose vs. Bone Marrow
While there are several sources of mesenchymal stem cells (MSCs), two of the most common sources include adipose tissue and bone marrow. At Personalized Stem Cells, we process adipose (fat) tissue to extract and concentrate MSCs for use in FDA-approved clinical...
Walking to Reduce Osteoarthritis Pain
Osteoarthritis (OA) is the most common form of arthritis. It is a degenerative disease in which the cartilage within a joint breaks down, causing changes in the surrounding bone. Common symptoms of OA include pain, stiffness, and reduced range of motion. While any...
First Patients Treated in COVID-19 Stem Cell Clinical Trial
In 2020, Personalized Stem Cells developed and secured FDA approval for a COVID-19 stem cell clinical trial. In October of last year, we announced that we out-licensed our allogeneic stem cell program, including the COVID-19 therapy, to Sorrento Therapeutics....
A Long and Winding Road: Meet PSC President and COO Mike Dale
Mike Dale is President and Chief Operating Officer of Personalized Stem Cells, Inc. (PSC), and co-founder of our parent company, VetStem Biopharma. Mike’s journey is not the typical biotech career path. In the 1970’s Mike had no scientific or biotech aspirations or...
Knee Osteoarthritis Clinical Trial Update: Data Collection Milestone
2020 was a whirlwind of a year for most of us. Individuals, families, and businesses all over the world were affected by the global pandemic. Nobody expected the year’s crazy turn of events, and most of us found ourselves in uncharted territory when it came to...
Stem Cell Therapy for Traumatic Brain Injury
Stem cell therapy may be an effective treatment option for traumatic brain injury.
Personalized Stem Cells’ Parent Company Celebrates 15 Years as Biocom Member
Our parent company, VetStem Biopharma, recently reached their 15 year anniversary as a member of Biocom, a life science association.
Meet Dr. Robert Harman, Co-Founder and CEO of Personalized Stem Cells
Co-Founder and CEO of Personalized Stem Cells Inc., Dr. Robert Harman, has dedicated the majority of his career to developing stem cell therapy for humans and animals.